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Executive summary 
This National Drug Treatment Monitoring System (NDTMS) statistics report presents 
information about young people under the age of 18 who received specialist substance 
misuse treatment in England between 1 April 2017 and 31 March 2018.  
 
The number of young people in alcohol and drug specialist services  
There were 15,583 young people in specialist substance misuse services in 2017-18. 
This was a 5% decrease from 2016-17 (16,436) and a continuation of a year on year 
downward trend. There has been a 35% decrease since a peak in 2008-09 when 
24,053 young people received treatment.  
 
There are several factors which may have influenced this downward trend including the 
possibility that it reflected historic declining prevalence. However, there is recent 
evidence that the number of young people using drugs has started to increase, so the 
more recent decreases in young people accessing treatment services may not reflect 
the actual need. 
 
The latest NHS Digital survey of school age children ‘Smoking, drinking and drug use 
among young people in England’,1 conducted in 2016 showed nearly a fifth (18%) of 
pupils said that they had taken drugs in the last year. Excluding new psychoactive 
substances and nitrous oxide (newly added to the drug prevalence measure in 2016), 
15% said they had taken drugs in the last year, up from 10% in 2014. 
 
The Crime Survey for England and Wales 2017-182 also showed an increase in any 
class A drug use in the last year among 16-24 year olds, going from 6.8% in 2007-08 to 
8.4% in 2017-18. 
 
In addition to these surveys, Department for Education data for 2016-173 showed 
school exclusions for alcohol and drug use have increased substantially in recent years 
with fixed term exclusions up by 34% since 2012-13 and permanent exclusions up by 
95% since 2010-11.  
 
                                            
 
 
1 Smoking, drinking and drug use among young people in England. NHS Digital 2017 
digital.nhs.uk/data-and-information/publications/statistical/smoking-drinking-and-drug-use-among-young-people-in-
england/2016 
2 Drug misuse: findings from the 2017 to 2018 Crime Survey for England and Wales. Home Office 2018 
www.gov.uk/government/statistics/drug-misuse-findings-from-the-2017-to-2018-csew 
3 Permanent and fixed period exclusions in England: 2016 to 2017. Department for Education 2018 
www.gov.uk/government/statistics/permanent-and-fixed-period-exclusions-in-england-2016-to-2017 
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Problem substances 
Cannabis remained the most common drug by far that young people came to treatment 
for. The majority (88%) of young people in specialist services said they had a problem 
with this drug. The proportion of young people in treatment saying that cannabis is their 
main problem substance has been on an upward trend since 2007-08. Although total 
numbers have decreased slightly in recent years, the proportion of young people in 
treatment who have cannabis problems has remained stable in the last 2 years at 77%. 
 
The next most commonly reported problematic substance was alcohol. There were 
7,206 young people in treatment for alcohol problems (46%). The number of young 
people receiving help for alcohol problems continues to steadily decline from the peak 
in 2008-09 when 16,047 were treated for alcohol. 
 
The number of young people entering treatment for problems with ecstasy in 2017-18 
increased by 16% from the previous year (1,815 to 2,112) and has almost doubled 
since 2013-14. The increase in ecstasy treatment numbers was seen across all age 
groups.  
 
There was also an 18% increase in young people in treatment for crack problems over 
the same period, although the numbers were much lower (83 in 2016-17 and 98 in 
2017-18). There was also a rise in adults being treated for crack over the same period.4 
 
Benzodiazepine treatment is reported for the first time in this report. Young people who 
had problems with benzodiazepines at the start of treatment almost doubled from the 
previous year (161 in 2016-17 and 315 in 2017-18). Alprazolam (most commonly called 
Xanax) was the benzodiazepine which saw the biggest increase, (8 in 2016-17 to 53 in 
2017-18). 
 
Young people entering treatment for problems with new psychoactive substances 
(NPS) more than halved since the previous year (585 in 2016-17 and 270 in 2017-18) 
and is 74% lower than 2015-16 when 1,056 reported problematic use. Similar falls were 
seen in adults starting treatment over the same period, particularly in those under 25. 5 
  
                                            
 
 
4 Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS) 2017-18 
www.gov.uk/government/statistics/substance-misuse-treatment-for-adults-statistics-2017-to-2018 
5 Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS) 2017-18 
www.gov.uk/government/statistics/substance-misuse-treatment-for-adults-statistics-2017-to-2018 
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Gender and age 
Two-thirds of the young people accessing specialist substance misuse services were 
male (66%). Around three-quarters (74%) were aged 15 or over. The median age for 
both female and male was 15 years old. Only 43% of females were aged 16 or over 
compared to nearly half (49%) of males. 
 
While the number of younger children (under 14) in treatment remains relatively low, it 
has increased from last year (1,342 in 2016-17 to 1,422 in 2017-18).  
 
Any substance misuse among young people – particularly the younger age groups – is 
concerning because they are likely to be at risk of other harms as well as their alcohol 
or drug use. Safeguarding needs to be a priority and the other risks and harms need to 
be addressed. 
 
Referral route 
Education services was the most common route into specialist treatment services, with 
5,178 (31%) young people being referred from these. Mainstream education was the 
single largest source of referral, accounting for over a quarter of all referrals (26%, or 
4,432). The proportion referred by education services has increased over recent years 
(24% in 2012-13), while referrals from the youth justice system continue to decline 
(34% in 2012-13 to 22% in 2017-18).  
 
Vulnerabilities 
The majority of young people in specialist substance misuse services have other 
problems or vulnerabilities related to their substance use, such as: 
 
 having mental health problems 
 being in contact with children’s social care 
 not being in education, employment or training (NEET) 
 offending  
 self-harming  
 experiencing sexual exploitation  
 domestic abuse  
 
There are 17 vulnerability items collected via the NDTMS. Almost all (96%) of young 
people who entered treatment in 2017-18 disclosed 1 or more vulnerability, and 55% 
said they had 3 or more. This shows that specialist services need to work effectively 
with a range of other agencies to ensure that all the needs of a young person are met. 
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The number and proportion of young people reporting they had experienced sexual 
exploitation reduced in 2017-18 compared to the previous year (562 or 5% in 2017-18 
and 688 or 6% in 2016-17). However, this proportion varied greatly by gender: over 8 
out of 10 sexual exploitation reports were by females (470 female compared to 92 
male), accounting for 13% of all females starting treatment and 1% of males. While 
these figures suggest a difference between genders, Barnardo’s research6 found that 
boys tended not to disclose experience of sexual exploitation or abuse as much as 
girls. 
 
Mental health needs  
Information on whether a young person starting treatment has a mental health need 
was introduced into this report for the first time this year. Of all the young people 
starting treatment in 2017-18, who had given a mental health status, 2,954 (27%) said 
they had a mental health treatment need. There was a greater proportion of females 
reporting this than males (37% compared to 22%).  
 
Around 7 out of 10 of young people who reported a mental health treatment need also 
said that they were currently receiving treatment for their mental health (70% or 2,023). 
This proportion was broadly similar for males and females (72% of females and 69% of 
males). Most of the young people that recorded a mental health treatment need were 
either engaged with community mental health services (57%, or 1,648) or receiving 
treatment from their GP (9%, or 252).   
 
Waiting times and reasons for leaving specialist services 
Young people continued to be able to access treatment quickly in 2017-18. The mean 
waiting time for young people to start their first specialist intervention was around 2 and 
a half days. Nearly all (97%) of the 16,330 first interventions started by young people in 
2017-18 had a wait of 3 weeks or under and 77% of first interventions started on the 
day the young people were referred. 
 
Most (81%) young people that left services in 2017-18 did so in a planned way, no 
longer requiring specialist treatment interventions. Although this proportion is slightly 
lower than last year (82%), it still suggests that specialist substance misuse services in 
England are responding well to the needs of young people who access them, and are 
helping young people to overcome their substance misuse problems. 
  
                                            
 
 
6 Research on the sexual exploitation of boys and young men A UK scoping study Summary of findings August 2014 
Barnardo’s 2014 www.natcen.ac.uk/media/530798/16134-su-cse-young-boys-summary-report-v3.pdf 
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1. Background and policy context 
1.1 These statistics and their use 
The statistics in this report present information collected through the National Drug 
Treatment Monitoring System (NDTMS) about young people under the age of 18 who 
receive specialist substance misuse interventions in England. The information relates 
to all substances young people (YP) in specialist services sought help for, including 
alcohol.  
 
The statistics are used to: 
 
 inform the commissioning of specialist services for young people with drug and/or 
alcohol problems 
 monitor national availability and effectiveness of specialist substance misuse 
services for young people 
 monitor trends and shifts in patterns of drug and alcohol use among young people 
attending specialist services to inform future local and national public health policy 
 provide evidence about the benefits of attending specialist substance misuse 
services to young people and their families 
 inform the Government drug strategy  
 
The statistics in this report should therefore be considered as part of a wider picture 
around the needs of young people and prevention services for vulnerable young 
people.   
 
More detail on the methodologies used to compile these statistics and the processes in 
place to ensure data quality can be found at: www.ndtms.net/resources/public/Quality-
and-Methodology-NDTMS-2017-18.pdf 
  
If an error is identified in any of the information that has been included in this report, 
then the processes described in the Public Health England (PHE) revisions and 
correction policy will be adhered to. The policy can be found here at: 
www.gov.uk/government/organisations/public-health-england/about/statistics  
 
1.2 Specialist substance misuse services for young people 
Specialist substance misuse services for young people are distinct from adult treatment 
services because young people’s alcohol and drug problems tend to be different to 
those of adults and so they need a different response. This includes being child 
centred, considering the age and maturity of young people, supporting the young 
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people to ensure they are not mixing with more problematic adult drug users and acting 
on safeguarding concerns. 
 
The role of specialist substance misuse services is to support young people to address 
their alcohol and drug use, to reduce the harm it causes them and prevent it from 
becoming a greater problem as they get older. Services should operate as part of a 
wider network of universal and targeted prevention services, which aim to support 
young people with a range of issues and help them to build their resilience.7 
 
1.3 Policy context  
Last year the Home Office published the Government’s updated 2017 Drug Strategy, 
which aims to prevent the onset of drug use and its escalation at all ages, through 
universal action combined with more targeted action for the most vulnerable. This 
includes placing a greater emphasis on building resilience and confidence to young 
people to prevent the range of risks they face, e.g. drug and alcohol misuse, crime, 
exploitation and unhealthy relationships:  
www.gov.uk/government/publications/drug-strategy-2017  
 
In April 2018 the Government published its Serious Violence Strategy, which sets out 
the government’s response to serious violence and recent increases in knife crime, gun 
crime and homicide. It identified drugs as a key driver of recent increases in serious 
violence:  
www.gov.uk/government/publications/serious-violence-strategy 
 
In December 2017 the Government published the Mental Health Green Paper 
Transforming Children and Young People’s Mental Health. The actions in the Green 
Paper will provide a step towards a far more joined up approach to mental health 
support, not just across health and education but also other services – a multi-agency 
approach focused on collectively understanding and meeting the needs of children and 
young people: 
www.gov.uk/government/consultations/transforming-children-and-young-peoples-
mental-health-provision-a-green-paper 
 
Department for Education (DfE) is proposing to introduce statutory relationships 
education in primary schools, relationships and sex education in secondary schools 
and health education across both primary and secondary schools in September 2020 
                                            
 
 
7 Universal services can include school-based approaches to drug and alcohol education and prevention, delivered through 
PSHE. Targeted services can include specific interventions delivered to young people at significant risk of developing drug or 
alcohol problems, such as those involved in youth justice services, or non-mainstream education. 
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and to have early adopter schools that are willing to start teaching the new subjects 
from 2019. We expect regulations will be laid in the House, alongside final draft 
guidance, allowing for a full and considered debate in the first half/quarter of 2019. The 
final statutory guidance will be published once the regulations have been passed: 
consult.education.gov.uk/pshe/relationships-education-rse-health-education  
 
1.4 Prevalence of alcohol and drug use among young people 
NDTMS statistics do not provide an indication of the levels of need for young people’s 
specialist substance misuse services. The main prevalence data for trends in 
substance use among young people is the biennial schools survey ‘Smoking, drinking 
and drug use among young people in England’ for 11-15 year olds. 
 
The last survey which was conducted in 2016 reported an increase in lifetime 
prevalence of drug use, from 15% in 2014 to 24% in 2016, following a longer term 
falling trend. Part of this increase in overall drug use can be explained by the addition 
of questions on nitrous oxide (NO) and new psychoactive substances (NPS). However, 
even allowing for these, the estimate for 2016 is 21% which remains a large increase 
from 15% in 2014. One-tenth (10%) of pupils said that they had taken drugs in the last 
month, up from 6% in 2014. Although cannabis was the most commonly used drug 
among 11 to 15 year olds (with 7.9% reporting that they had used it in the last year), 
there was also an increase in the proportion reporting Class A drug use, from 2.0% in 
2014 to 3.2% in 2016.  
 
The schools survey shows that 44% of pupils had ever drunk alcohol. By the age of 15, 
73% of teenagers had tried alcohol and almost a quarter of 15 year olds reported that 
they had an alcoholic drink in the last week. This figure is not comparable with earlier 
surveys due to a change in methodology, but is regarded by the authors as more 
accurate than estimates of lifetime prevalence from previous iterations of this survey. It 
is important to note that 9% of pupils said they had been drunk in the last 4 weeks, 
including 7% of pupils who had been drunk once or twice, and 2% more often. Girls 
(11%) were more likely to have been drunk in the last 4 weeks than boys (7%). 
England, however, still has a relatively high incidence of regular drinking, drunkenness 
and cannabis use among 15 year olds compared to other European countries.8 
 
The latest Smoking, drinking and drug use among young people in England report for 
2016 can be found at: digital.nhs.uk/catalogue/PUB30132 
 
                                            
 
 
8 Health Behaviour in School-aged Children (HBSC): World Health Organisation Collaborative Cross National Study (Brooks, 
F. et al., 2015) 
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Prevalence statistics for young adults aged 16-24 are included in the ‘Drug Misuse: 
Findings from the 2017-18 Crime Survey for England and Wales’ (CSEW) report. The 
report has consistently found that younger people are more likely to have taken drugs 
in the last year than older people. Around 1 in 5 (19.8%) adults aged 16 to 24 had 
taken a drug in the last year. This proportion was more than double that of the wider 
age group, and equates to around 1.2 million people. There is an upward trend in the 
use of Class A drugs among 16 to 24 year olds with a statistically significant rise from 
6.8% in 2007/08 to 8.4% in 2017/18.    
 
The latest CSEW report can be found at: 
assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data
/file/729249/drug-misuse-2018-hosb1418.pdf 
 
DfE publish data on the number of permanent and fixed term exclusions where alcohol 
or drug use is recorded as the reason for exclusion. The number of fixed term 
exclusions for alcohol or drug use has risen from 7,360 in 2011/12 to 8,820 in 2016/17. 
Permanent exclusions for alcohol or drug use have risen from 330 to 565 over the 
same period.  
 
The latest DfE data on school exclusions can be found at: 
www.gov.uk/government/statistics/permanent-and-fixed-period-exclusions-in-england-
2016-to-2017 
 
1.5 Other risk factors affecting young people  
Acute harm from drug and alcohol use can happen to anybody, but problematic drink 
and drug use among under-18s rarely occurs in isolation and is frequently a symptom 
of wider problems.  
 
Evidence suggests that there are a number of risk factors (or vulnerabilities) associated 
with young people misusing substances, being harmed by those substances and going 
on to develop drug or alcohol problems as adults. These risk factors include 
experiencing domestic abuse and sexual exploitation, truanting from school, offending, 
early sexual activity, antisocial behaviour, mental health problems and being exposed 
to parental substance misuse.  
 
Findings from the Health Behaviour in School-aged Children (HBSC) report4 also 
suggest that while drinking alcohol during adolescence is to some extent a normative 
aspect of young people’s development, excessive drinking and drunkenness (and 
particularly early initiation to drinking) is associated with increased risk of injury, 
unplanned and unprotected sex, and alcohol disorders and dependency. It also reports 
that cannabis use during adolescence has been associated with decreased 
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performance on learning and memory tasks, lower academic attainment, other illicit 
drug dependency, and suicide attempts. 
 
An analysis of the HBSC survey for England carried out for PHE showed that among 
girls, those with the lowest life satisfaction were found to be more likely to have both 
consumed alcohol in the last month and ever been drunk (consumed alcohol to 
excess), and 10 times as likely to report having smoked tobacco in the last month than 
those with the highest life satisfaction. They were also more likely to report having ever 
used cannabis, having had sex, and being involved in physical fighting. The report can 
be found at: 
www.gov.uk/government/uploads/system/uploads/attachment_data/file/621069/Health_
behaviour_in_school_age_children_wellbeing_of_adolescent_girls.pdf 
 
The Mental Health of Children and Young People in England, 2017, has been 
published by NHS digital. Risky health behaviours were more common in young people 
with a mental disorder. Alcohol use was more common in 11 to 16 year olds with a 
mental disorder. They were also more likely to drink more frequently. Illicit drug use 
was 3 times more likely in 11 to 16 year olds with a mental disorder (13.9%) than in 
those without one (4.1%). Girls aged 11 to 16 with a disorder were 5 times more likely 
to have tried drugs (14.2%) than girls without a disorder (2.6%). The report can be 
found at: digital.nhs.uk/data-and-information/publications/statistical/mental-health-of-
children-and-young-people-in-england/2017/2017 
 
PHE’s National Child and Maternal Health Intelligence Network is also available to local 
authorities and provides a wide-range of authoritative data, evidence and practice 
related to children's, young people's and maternal health. A guidance page which 
explains how health professionals can use child and maternal health data and 
intelligence to help make decisions about the planning and provision of services is 
available here: www.gov.uk/guidance/child-and-maternal-health-data-and-intelligence-
a-guide-for-health-professionals 
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2. Assessment of quality and robustness of 
2017-18 NDTMS community data 
NDTMS data is routinely collected by PHE. Drug and alcohol treatment providers 
submit a monthly extract. From 2017 onwards, this extract is automatically validated by 
the NDTMS collection system. Data submissions are automatically aggregated and 
reconciled against previous submissions to create a single national data submission. 
PHE operates a continual programme of improvement and treatment providers work 
with their local NDTMS team to improve each monthly submission throughout the year. 
 
The data quality of NDTMS is extremely important as it provides PHE with assurances 
that the data is an accurate representation of actual activity and it is therefore usable 
and reliable. It also gives confidence to the user of these statistics that the appropriate 
checks and balances have been applied. 
 
As part of the Core Dataset N (CDSN) changes that were introduced in April 2017, 
young people with an identified mental health problem was replaced by mental health 
treatment need and the types of treatment received by clients for their mental health 
needs were added to the core dataset. Data completeness of these new variables is 
lower than the rest of the dataset, but is expected to increase over time for these 
variables as the reporting process beds in across the treatment system. 
 
Table 2.1.1 provides an overview of the quality of data submitted to NDTMS by young 
people treatment services since 2014-15. The proportion of valid records received out 
of all submitted records along with the proportion of records received without errors or 
warnings are included as they indicate the general level of data quality across the 
broad spectrum of information collected at each monthly data submission. Three 
additional indicators are also included below that report on the proportion of duplicate 
or overlapping treatment interventions and episodes. These are reported as they 
provide a sense of how accurate and efficient record keeping is at treatment provider 
level. A low proportion is desirable as it demonstrates robust administrative functions at 
a national level. 
 
More detailed information on NDTMS data collection and full definitions for the data 
quality measures recorded in Table 2.1.1 can be found at: 
www.ndtms.net/resources/public/Quality-and-Methodology-NDTMS-2017-18.pdf 
In addition to the data quality checks taken at data submission, there are data quality 
checks and validation rules used in the production of this report. The rate of completion 
for report items range from 100% to 97%. Where items are under 100% this implies it is 
either due to missing data for that item or conflicting information has been entered for 
the same individual. 
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Table 2.1.1 Data quality of NDTMS 
 
Data quality measure 2014-15 2015-16 2016-17 
Proportion of submitted records that were valid 100% 100% 100% 
Proportion of records without errors or warnings 99.93% 99.95% 99.96% 
Proportion of duplicate treatment episodes recorded at the 
same provider 
0.17% 0.00% 0.00% 
Proportion of overlapping treatment episodes recorded at 
the same provider 
0.08% 0.04% 0.01% 
Proportion of duplicate treatment interventions recorded at 
the same provider 
0.11% 0.00% 0.00% 
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3. Characteristics of clients 
NDTMS reported a total of 15,583 young people aged 9-179 in contact with specialist 
substance misuse treatment services from 1 April 2017 to 31 March 2018. This is a 
decrease of 5% (853 individuals) from 2016-17 (16,436 individuals). A comparison over 
the years is provided in section 6. 
 
3.1 Age and gender of all young people in treatment 
The age and gender of young people at their first point of contact with the treatment 
system in 2017-18 is reported in Table 3.1.1 and Figure 3.1.1. In 2017-18, two-thirds 
(66%) of young people in treatment were male, which is the same proportion as in 
2016-17, but is higher than the proportion in the general population in England where 
51% of 9-17 year old are male.10  
 
About 1 in 4 (26%) young people in treatment were under the age of 15. Although the 
number of younger children under the age of 14 in treatment was comparatively lower 
than other age groups, it has increased by 6% from last year (1,342 in 2016-17 to 
1,422 in 2017-18). The median age for both female and male was 15 years old. Only 
43% of females were aged 16 or over compared to nearly half (49%) of males. 
 
The 2016 Smoking, Drinking and Drug use among young people survey (SDD)11 
showed an increase in lifetime prevalence of drug use among 11 to 15 years olds in 
2016. It is important to note that the findings from the 2016 SDD survey and what has 
been observed on NDTMS are not directly related due to the differences in the 
methodologies. However any substance use in this age group is a concern as they are 
likely to be at a greater risk of harm. Safeguarding should be a priority for these 
individuals and their wider needs should be addressed alongside their substance 
misuse. 
 
 
 
 
                                            
 
 
9 For age methodology please refer to the quality and Methodology information document at 
www.ndtms.net/resources/public/Quality-and-Methodology-NDTMS-2017-18.pdf 
10 Annual mid-year population estimates, 2017 
www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulati
onestimates/mid2017 
11 Smoking, Drinking and Drug Use Among Young People in England – 2016 
digital.nhs.uk/data-and-information/publications/statistical/smoking-drinking-and-drug-use-among-young-people-in-
england/2016 
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Table 3.1.1 Age and gender of all young people in treatment 2017-18 
 
Age 
Female Male Total 
n % n % n % 
Under 12 12 <1% 46 <1% 58 <1% 
12-13 122 2% 179 2% 301 2% 
13-14 414 8% 649 6% 1,063 7% 
14-15 977 19% 1,638 16% 2,615 17% 
15-16 1,477 28% 2,725 26% 4,202 27% 
16-17 1,180 22% 2,495 24% 3,675 24% 
17-18 1,067 20% 2,602 25% 3,669 24% 
Total clients 5,249 100% 10,334 100% 15,583 100% 
 
Figure 3.1.1 Age and gender distribution of all young people in treatment 2017-18 
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3.2 Ethnicity of all young people in treatment  
Table 3.2.1 and Figure 3.2.1 show the ethnicity of young people in treatment in 2017-
18. Where reported, the majority of young people (76%) in treatment services were 
white British. This is similar to the general population, where 78% of young people 
aged 10 to 17 were white British according to the 2011 census.12 For the remaining 
clients, 4% were other white and 3% were white and black Caribbean or Caribbean. No 
more than 2% reported any other ethnic group. 
 
Table 3.2.1 Ethnicity of all young people in treatment 2017-18 
 
Ethnicity n % 
White British 11,848 76% 
Other white 607 4% 
White and black Caribbean 465 3% 
Caribbean 398 3% 
Other mixed 333 2% 
African 256 2% 
Not stated 240 2% 
Other black 225 1% 
Other 203 1% 
Pakistani 190 1% 
White and Asian 166 1% 
Other Asian 142 1% 
White and black African 125 1% 
Bangladeshi 123 1% 
Indian 93 1% 
White Irish 75 <1% 
Chinese 6 <1% 
Total 15,495 100% 
Missing or inconsistent data 88   
Total 15,583   
 
  
                                            
 
 
12 2011 Census - ONS 
www.ons.gov.uk/census/2011census 
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Figure 3.2.1 Ethnicity all young people in treatment 2017-18 
3.3 Substance use 
The substance(s) cited by young people in specialist treatment in 2017-18 are reported 
in Table 3.3.1 and Figure 3.3.1 and are broken down by primary and adjunctive use. 
Primary substance use is the substance that brought the young person into treatment 
at the point of triage (initial assessment) and adjunctive substance use is any other 
substance(s) cited by the young person. If a young person was seen at more than 1 
service provider or was in treatment multiple times within the year, only the 
substance(s) recorded in the latest treatment episode is (are) reported in this section. 
For further details of the methodology, see: www.ndtms.net/resources/public/Quality-
and-Methodology-NDTMS-2017-18.pdf 
 
The majority (88%) of young people reported cannabis as either a primary or adjunctive 
problematic substance in 2017-18, which was the same proportion as last year. The 
second most cited substance was alcohol (46%), which was slightly lower than the 
proportion reported in 2016-17 (49%). Ecstasy was cited by 14% of young people in 
2017-18, which is an increase from 2016-17 (11%). The proportion who cited cocaine 
also increased slightly to 10% in 2017-18 (from 9% in 2016-17). 
 
Benzodiazepines are reported separately from the ‘other substances’ category for the 
first time this year. There were 315 (2%) young people who needed help with 
problematic benzodiazepine use in 2017-18, which was almost double the number in 
2016-17 (161). The proportion of young people reporting nicotine (adjunctive use only) 
as a problematic substance was the same as in 2016-17 (16%). 
 
The proportion of young people citing new psychoactive substances (NPS) decreased 
from 4% in 2016-17 to 2% in 2017-18. The proportion of young people reporting 
amphetamines decreased from 3% in 2016-17 to 2% in 2017-18. The number of young 
people reporting crack increased from 83 in 2016-17 to 98 in 2017-18, accounting for 
White British
76%
Other White
4%
White and black Carribean
3%
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3%
All others
14%
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around 1% of those in treatment. Individuals citing heroin decreased from 98 in 2016-
17 to 66 in 2017-18 while the number reporting other opiates, increased from 83 in 
2016-17 to 120 in 2017-18. 
 
The median age of young people in specialist services was 15 years, which is the same 
as last year. In 2016-17, the median age of young people in treatment for primary 
cannabis, alcohol, ecstasy and solvents use was 15 years and those in treatment for 
primary heroin and crack use had a higher median age of 17 years. More information 
on substance use by age is shown in Table 3.3.2 and the trends in presenting 
substances can be found in section 6. 
 
Table 3.3.1 Substance use of all young people in treatment 2017-18 
 
Substance 
Primary Adjunctive1 Total1 Primary 
n % n % n % 
median 
age 
Cannabis 12,066 77% 1,647 11% 13,713 88% 15 
Alcohol 2,265 15% 4,941 32% 7,206 46% 15 
Ecstasy 454 3% 1,658 11% 2,112 14% 15 
Cocaine 287 2% 1,208 8% 1,495 10% 16 
Other2 105 1% 573 4% 678 4% 16 
Solvents 102 1% 285 2% 387 2% 15 
Benzodiazepines3 75 <1% 240 2% 315 2% 16 
Amphetamines 39 <1% 232 1% 271 2% 16 
New psychoactive substances 73 <1% 197 1% 270 2% 16 
Other opiates4 37 <1% 83 1% 120 1% 16 
Crack 31 <1% 67 <1% 98 1% 17 
Heroin 39 <1% 27 <1% 66 <1% 17 
Nicotine (adjunctive use only) - - 2,486 16% - - - 
Total 15,573             
Missing, misuse free or inconsistent data 10             
Total including missing 15,583             
 
 
 
   
    
1 Adjunctive and the total percentages are out of all young people in treatment (15,583) 
2 ‘Other’ incorporates a number of different substance categories which are not shown elsewhere in the table. A single young 
person may be counted under both primary and adjunctive ‘other’ if the substances are from different categories. Therefore, 
primary and adjunctive users cannot be summed to give a total number of users. 
3 Benzodiazepine is reported separately from ‘other’ substances this year 
4 'Other opiates' includes ethoheptazine, Oxycodone, Opium and Fentanyl. 
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Figure 3.3.1 Substance use of all young people in treatment 2017-18 (primary and adjunctive substances) 
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Table 3.3.2 Substance use (primary or adjunctive)1 of all young people in treatment 2017-18 by age group 
 
 
            
Substance 
Under 132 13-14 14-15 15-16 16-17 17-18 
n % n % n % n % n % n % 
Cannabis 261 73% 874 82% 2,268 87% 3,790 90% 3,330 91% 3,190 87% 
Alcohol 162 45% 468 44% 1,243 48% 1,939 46% 1,644 45% 1,750 48% 
Ecstasy 22 6% 112 11% 334 13% 575 14% 547 15% 522 14% 
Cocaine 9 3% 33 3% 135 5% 326 8% 410 11% 582 16% 
Solvents 22 6% 35 3% 77 3% 118 3% 73 2% 62 2% 
Benzodiazepines * - 5 <1% 45* ~2% 69 2% 86 2% 110 3% 
Amphetamines * - 10* ~1% 24 1% 73 2% 75 2% 87 2% 
New psychoactive substances * - 20* ~2% 38 1% 60 1% 68 2% 82 2% 
Opiates3 0 0% 7 1% 19 1% 35 1% 58 2% 68 2% 
Crack 0 0% * - * - 15 <1% 26 1% 52 1% 
Total4 359   1,063 
 
2,615 
 
4,202   3,675   3,669   
 
 
 
             
1 Primary and adjunctive use are combined in this table, therefore a young person may be counted more than once.  
Refer to Table 3.3.1 for a breakdown of primary and adjunctive use. 
2 Due to very low numbers for some substances, young people under the age of 12 and those from 12 to 13 years old have been grouped together to ‘under 13’ years old. 
3 Due to low numbers when breaking down by age, figures for heroin, methadone and other opiates are collapsed into a single opiates category in this table. A single young person 
may therefore be counted as both a primary and adjunctive opiate user, and therefore the sum of primary and adjunctive opiate users may be greater than the total number of opiate 
users. 
4 Total in this table is the total number of individuals in the corresponding age group and not the sum of all instances in the column 
* All numbers under 5 have been suppressed. Where these could be derived, the next age group figures have been rounded to the nearest 5 and marked with an asterisk.
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3.4 Source of referral into treatment (for treatment episodes) 
Figure 3.4.1 and Table 3.4.1 show the breakdown of treatment episodes in 2017-18 by 
the source of referral. The source of referral was provided for 16,837 (99.9%) episodes 
of treatment. An individual may have more than 1 treatment episode in the year and all 
episodes are counted. Therefore, the total number reported in this section is different 
from the total number of young people in treatment in 2017-18. 
 
Education (31%) was the most common route into specialist treatment services, with 
mainstream education being the single largest source of referral accounting for over a 
quarter of all referrals (26%). The youth justice system was the second most common 
referral route (22%), although this has been declining as a proportion of referrals in 
recent years (39% in 2010-11). Youth offending teams (YOT) were the single largest 
source of referral (18%) within this category. 
 
Referrals from social care services accounted for 16% of all recorded referrals in 2017-
18. The proportion for this referral route has increased from 10% in 2012-13 (from 
2,275 to 2,734). Children and family services referrals was the largest single referral 
source in this group and accounted for 14% of all referrals. Accident and emergency 
(A&E) referrals accounted for 1%, while referrals from child and adolescent mental 
health services (CAMHS) accounted for 5%. Referrals from A&E and CAMHS may be 
lower than expected, based on the available hospital admissions data and evidence 
about the links between young people’s mental health and substance misuse and the 
use of these services by young people.13 14 15 
 
 
 
 
 
 
 
 
 
                                            
 
 
13 Future in mind, Promoting, protecting and improving our children and young people’s mental health and wellbeing, DH, NHS 
England, 2015.  
14 www.gov.uk/guidance/child-and-maternal-health-data-and-intelligence-a-guide-for-health-professionals 
15 PHE/Royal College of Emergency Medicine Young people’s hospital alcohol pathways: Support pack for A&E departments 
2014 www.nta.nhs.uk/uploads/young-peoples-hospital-alcohol-pathways-support-pack-for-ae-departments.pdf 
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Figure 3.4.1 Source of referral of all treatment episodes 2017-18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4.1 Source of referral of all treatment episodes 2017-18 
 
Referral Source n % 
Mainstream education 4,432 26% 
Alternative education 702 4% 
Education service and other 44 <1% 
Education total 5,178 31% 
YOT 3,042 18% 
YP secure estate 273 2% 
Other 408 2% 
Youth / criminal justice total 3,723 22% 
Children and family services 2,425 14% 
Looked after child services 293 2% 
Social services 16 <1% 
Social care total 2,734 16% 
Self 938 6% 
Relative, family, friend or concerned other 979 6% 
Self, family & friends total 1,917 11% 
Substance misuse total 1,204 7% 
CAMHS 784 5% 
School nurse 373 2% 
A&E 251 1% 
GP 182 1% 
Hospital 134 1% 
Other 73 <1% 
Health total 1,797 11% 
YP housing 259 2% 
Other 25 <1% 
Total (episodes) 16,837   
Missing or inconsistent data 48   
Total (episodes) 16,885   
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3.5 Education and employment status of new presentations to treatment 
Figure 3.5.1 and Table 3.5.1 show the education and employment status at 
presentation to treatment of new presentations. In 2017-18, 10,843 (98%) young 
people provided information about their education and employment status when they 
entered treatment. Of these, 57% were recorded as being in mainstream education 
(such as schools and further education colleges) and nearly a fifth (19%) in alternative 
education (such as schooling delivered in a pupil referral unit or home setting). A 
further 16% were recorded as not in employment, education or training (NEET). This 
profile was broadly similar to 2016-17. 
 
Figure 3.5.1 Education and employment status of all young people starting  
treatment in 2017-18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5.1 Education and employment status of young people starting  
treatment in 2017-18 
 
Education and employment status n % 
Mainstream education 6,138 57% 
Alternative education 2,058 19% 
Not in employment or education or training (NEET) 1,683 16% 
Apprenticeship or training 428 4% 
Employed 296 3% 
Persistent absentee or excluded 212 2% 
Economically inactive – health issue or caring role 17 <1% 
Voluntary work 11 <1% 
Total 10,843   
Missing or inconsistent data 209   
Total new presentations 11,052   
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3.6 Accommodation status 
Table 3.6.1 shows the housing situation at treatment entry of young people in 
treatment. This was recorded for 15,355 (99%) young people in treatment in 2017-18. 
 
The majority of young people in treatment who reported their accommodation status 
(85%) were living with their parents or other relatives, while a further 3% reported living 
independently in settled accommodation. Seven per cent of young people stated that 
they were living in care, with less than 1% living in secure care (accommodation within 
any secure setting where a young person has been placed). The proportions were 
broadly similar to 2016-17. 
 
Table 3.6.1 Accommodation status of all young people in treatment 2017-18 
 
Accommodation status n % 
Living with parents or other relatives 13,107 85% 
YP living in care 1,093 7% 
YP supported housing 551 4% 
Independent – settled accommodation / no housing problem 389 3% 
Independent – unsettled accommodation / housing problem 127 1% 
Independent – no fixed abode 45 <1% 
YP living in secure care 43 <1% 
Total 15,355   
Missing or inconsistent data 228   
Total 15,583   
 
 
3.7 Vulnerabilities 
Young people often enter specialist substance misuse services with a range of problems or 
vulnerabilities relating to or in addition to their substance use, such as using multiple 
substances, having mental health treatment need, being a ‘looked after child’ or having a 
NEET status. Apart from these vulnerabilities, other wider risk factors can also impact on their 
substance use (such as self-harming behaviour, sexual exploitation, offending or domestic 
abuse). 
 
The NDTMS collects information on 17 vulnerability factors and the details of these 
items are shown in Table 3.7.1. These are the range of risk factors that are most likely 
to be associated with problematic substance misuse among young people. 
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Table 3.7.1 Description of vulnerability factors identified via NDTMS 
 
Vulnerability factor Criteria 
Early onset Began using primary substance under the age of 15 
Poly substance user Reported using 2 or more substances in combination (poly substance 
use) 
 
Antisocial behaviour Young person has been involved in antisocial behaviour or committed a 
criminal act on more than 1 occasion in the past 6 months (this is the 
offending behaviour disclosed by the individual, not convictions) 
 
Affected by others' 
substance misuse 
Is affected by others’ substance misuse in their close family and/or 
members of the household 
 
Affected by domestic 
abuse 
Has been affected by domestic abuse 
Mental health treatment 
need 
The young person has indicated that they have a mental health treatment 
need 
Self-harm Reported self-harming behaviour 
NEET Is not in education, employment or training 
Looked after child Has a ’looked after child’ status (see section 7.2) 
Child protection plan The young person is subject to a child protection plan 
Child in need Is a child in need 
Sexual exploitation Reported sexual exploitation 
High-risk alcohol user Drinks almost daily, or in excess of 8 units (males) or 6 units (females) 
on an average drinking day when drinking 13 or more days of the month 
Housing problem Reports unsettled accommodation status or has no fixed abode 
Pregnant and/or parent Is pregnant or a parent 
Opiate and/or crack use Reported using opiates and/or crack among their presenting substances 
Injecting Has ever injected (currently or previously) 
 
Vulnerabilities are reported only for new clients entering specialist services during the 
year and therefore the total number of clients in this section (11,052) is lower than the 
total number of young people in treatment in 2017-18. An individual young person may 
report multiple vulnerabilities and therefore the percentages in this table may sum to 
more than 100%. Table 3.7.2 shows the vulnerabilities reported by young people 
entering treatment in 2017-18. 
 
Similar to last year, the most commonly reported vulnerability was early onset of 
substance misuse, with 77% reporting use of their primary substance under the age of 
15. This was a 7% decrease compared to last year, where 84% reported this. The 
second most commonly reported vulnerability factor was poly substance use, a 
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common term for using more than 1 substance (57%). Approximately one-third of 
young people entering treatment since April 2017 (32%) reported involvement in 
antisocial behaviour or criminal activity. This was similar to the proportion in 2016-17 
(32%). Twenty-seven per cent (27%) indicated that they had a mental health treatment 
need.  
 
Over one-fifth of young people (22%) reported that they were affected by others’ 
substance misuse and 19% were affected by domestic abuse. The least commonly 
reported vulnerability was injecting (1%). Females presenting to treatment services 
were likely to cite a different range of vulnerabilities compared to males. Females were 
more likely to report increased instances of self-harm, sexual exploitation (see section 
3.8), mental health treatment need (see section 3.9) or domestic abuse, while males 
were more likely to report antisocial behaviour (38% of males compared to 20% of 
females). 
 
Table 3.7.2 Individual vulnerabilities identified among young people starting treatment 
in 2017-18 
 
Vulnerability 
Female Male Total 
n % n % n % 
Early onset of substance misuse 2,903 80% 5,651 76% 8,554 77% 
Poly drug user 2,327 64% 3,994 54% 6,321 57% 
Antisocial behaviour 721 20% 2,797 38% 3,518 32% 
Mental health treatment need 1,339 37% 1,615 22% 2,954 27% 
Affected by others' substance misuse 994 27% 1,424 19% 2,418 22% 
Affected by domestic abuse 913 25% 1,175 16% 2,088 19% 
NEET 458 13% 1,296 17% 1,754 16% 
Self-harm 999 28% 595 8% 1,594 14% 
Looked after child 455 13% 749 10% 1,204 11% 
Child in need 400 11% 557 8% 957 9% 
Child Protection Plan 389 11% 440 6% 829 8% 
Sexual exploitation 470 13% 92 1% 562 5% 
High risk alcohol user 184 5% 120 2% 304 3% 
Opiate and/or crack use 90 2% 151 2% 241 2% 
Pregnant and/or parent 94 3% 126 2% 220 2% 
Housing problem 70 2% 72 1% 142 1% 
Injecting 37 1% 41 1% 78 1% 
Total new presentations 3,627 
 
7,425 
 
11,052 
 
 
The number of vulnerabilities reported by young people in 2017-18 is reported in Table 
3.7.3. Individuals with substance misuse problems are more likely to experience other 
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social exclusion problems such as poor health, crime, unemployment and community 
deprivation.16  
 
The majority (96%) of young people entering treatment in 2017-18 reported at least 1 
vulnerability item. In 2017-18, there was a reduction in the proportion of young people 
reporting 2 or more vulnerability factors compared to 2016-17 (80% in 2016-17 and 
79% in 2017-18). Thirty-five per cent of young people reported 4 or more 
vulnerabilities, 44% cited 2 or 3, 17% reported 1 item and only 4 % reported no 
vulnerabilities in 2017-18. These proportions were broadly similar to 2016-17. 
 
Table 3.7.3 Number of vulnerabilities reported by young people starting treatment in 
2017-18 
 
Number of vulnerabilities reported (of total of seventeen) n % 
Zero 441 4% 
One 1,896 17% 
Two 2,640 24% 
Three 2,170 20% 
Four or more 3,905 35% 
Total new presentations 11,052 100% 
 
3.8 Sexual exploitation 
Child sexual exploitation (CSE) is a form of child sexual abuse.17 It occurs when an 
individual or group takes advantage of an imbalance of power to coerce, manipulate or 
deceive a child or young person under the age of 18 into sexual activity in exchange for 
something the victim needs or wants and/or for the financial advantage or increased 
status of the perpetrator or facilitator. 
 
The victim may have been sexually exploited even if the sexual activity appears 
consensual. Child sexual exploitation does not always involve physical contact; it can 
also occur through the use of technology. Department for Education have produced 
guidance around CSE, including this definition, which can be found at: 
assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data
/file/591903/CSE_Guidance_Core_Document_13.02.2017.pdf 
 
CSE has important health and wellbeing implications for children and young people and 
a number of reports have highlighted that substance misuse could be an indicator of 
                                            
 
 
16  Neale, J. (2006) Social Exclusion, Drugs and Policy. In R. Hughes, R. Lart & P. Higate (Eds.), 
Drugs, Policy and Politics (pp. 1-17). England: Open University Press. 
17 Child sexual exploitation: definition and guide for practitioners:  
www.gov.uk/government/publications/child-sexual-exploitation-definition-and-guide-for-practitioners 
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child sexual exploitation and abuse. Young people’s substance misuse services need 
to ensure that they are responding appropriately. PHE has published guidance on how 
public health can support prevention and intervention. The guidance can be accessible 
at: 
www.gov.uk/government/uploads/system/uploads/attachment_data/file/629315/PHE_c
hild_exploitation_report.pdf  
 
The age and gender breakdown of young people reporting CSE compared with all new 
presentations is shown in Table 3.8.1 and Figure 3.8.1. There were 562 individuals who 
reported CSE in 2017-18 compared to 688 in 2016-17. There was a higher proportion 
of females starting treatment in 2017-18 who reported CSE than males (13% and 1%, 
respectively). It is important to note that identifying CSE in boys and young men may 
be difficult as they are less likely to disclose abuse18 and the rate of CSE, particularly in 
males, may be higher than reported. Females who report CSE were more likely to be 
under the age of 15 (35%) compared to males (26%). The majority of males who 
reported CSE were aged 15 (30%) and one-quarter (25%) of females in the same age 
group reported CSE. 
 
Table 3.8.1 Age and gender breakdown of young people starting treatment in 2017-18 
who reported sexual exploitation 
 
Age 
Sexual exploitation Total new presentations 
Female Male Female Male 
n % n % n % n % 
Under 14 51 11% 10 11% 433 12% 687 9% 
14-15 112 24% 14 15% 745 21% 1,274 17% 
15-16 117 25% 28 30% 1,010 28% 1,924 26% 
16-17 107 23% 25 27% 723 20% 1,667 22% 
17-18 83 18% 15 16% 716 20% 1,873 25% 
Total new presentations 470 100% 92 100% 3,627 100% 7,425 100% 
 
 
 
 
 
 
 
 
 
 
 
                                            
 
 
18 Research on the sexual exploitation of boys and young men A UK scoping study Summary of findings August 2014 
Barnardo’s 2014 www.natcen.ac.uk/media/530798/16134-su-cse-young-boys-summary-report-v3.pdf. 
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Figure 3.8.1 Gender breakdown of young people starting treatment in 2017-18 who 
reported sexual exploitation 
 
 
3.9 Mental health treatment need 
Table 3.9.1 shows the gender breakdown of young people who started treatment in 
2017-18 and reported a mental health treatment need and the type(s) of treatment they 
received for their mental health needs.  
 
In 2017-18, a total of 2,954 (27%) young people reported a mental health treatment 
need at treatment start. The proportion of females who started treatment in the year 
with a mental health treatment need was higher than males (37% compared to 22%). 
The majority (70%) of young people with a mental health treatment need received 
some form of treatment for their treatment need(s). Over half (57%) of young people 
with a mental health treatment need were engaged in treatment with community mental 
health teams or other mental health services and 9% were in mental health treatment 
with their GP. 
 
 
 
 
 
 
 
 
0%
5%
10%
15%
20%
25%
30%
35%
Female Male Female Male Female Male Female Male Female Male
Under 14 14-15 15-16 16-17 17-18
CSE New presentation
Young people’s misuse statistics from NDTMS 
32 
Table 3.9.1 Mental health treatment need in 2017-18 
 
Mental health treatment need 
Female Male Total 
n % n % n % 
Engaged with community mental health team or 
other mental health services 
764 59% 884 56% 1,648 57% 
Mental health treatment from GP 114 9% 138 9% 252 9% 
NICE recommended mental health treatment 35 3% 35 2% 70 2% 
Engaged with Improving Access to Psychological 
Therapies (IAPT) 
10 1% 18 1% 28 1% 
Identified space in a health based place of safety 
for mental health crises 
8 1% 17 1% 25 1% 
Total individuals receiving any form of mental 
health treatment 
931 72% 1,092 69% 2,023 70% 
Mental health treatment need identified but no 
treatment received 
367 28% 484 31% 851 30% 
Total 1,298 100% 1,576 100% 2,874 100% 
Missing 41   39   80   
Total individuals with mental health treatment 
need 
1,339 37% 1,615 22% 2,954 27% 
Total new presentations 3,627   7,425   11,052   
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4. Access to services 
4.1 Waiting times for first and subsequent treatment interventions 
The time between being first identified as having a treatment need and being offered an 
appointment to start treatment intervention is known as the waiting time for an 
intervention. Table 4.1.1 reports the breakdown of waiting times up to and over 3 
weeks by first and subsequent interventions, i.e. where a client who is already receiving 
an intervention is referred on to start another type of treatment. Overall, nearly all 
young people (97%) waited no more than 3 weeks from first being identified as having 
a treatment need to being offered an appointment to start an intervention and 77% of 
first interventions started on the day the young people were referred. There were 983 
subsequent interventions of which 955 (97%) waited no more than 3 weeks. The 
average (mean) waiting time to commence treatment (first intervention only) was about 
2 and a half days. 
 
Table 4.1.1 Waiting times: first and subsequent interventions 2017-18 
 
Intervention 
3 weeks or under Over 3 weeks Total 
n % n % n % 
First Intervention 15,907 97% 423 3% 16,330 100% 
Subsequent Intervention 955 97% 28 3% 983 100% 
Total Interventions 16,862 
 
451 
 
17,313 
 
 
4.2 Treatment interventions 
When young people spend time in treatment, they can undergo 1 or more types of 
treatment, known as interventions, and may attend more than 1 service for subsequent 
interventions. For instance, the young person might receive a one-to-one intervention, 
such as motivational interviewing, in addition to a family intervention.  
 
From 1 November 2013, there was a change to the way NDTMS records these 
interventions. There are now 3 high-level structured intervention types (psychological, 
specialist harm reduction and pharmacological). To each high-level intervention, an 
intervention setting is recorded. 
 
The intervention types received by young people in contact with structured treatment is 
shown in Tables 4.2.1 and 4.2.2. Table 4.2.1 shows the number of clients who received 
a pre-November 2013 dataset change intervention that cannot be mapped directly to 
the current method of recording. Section 7.2 of this report contains more detail on this 
change. Individuals are counted once for each type of intervention they received. 
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Table 4.2.2 provides information on interventions that commenced after the changes to 
the core dataset on 1 November 2013. If an individual’s intervention can be directly 
mapped to the current method of reporting, it is shown in Table 4.2.2 and is removed 
from Table 4.2.1 above to avoid double counting. 
 
Overall, psychosocial interventions are the most common form of treatment with 93% of 
the total number of young people receiving them (14,308). Psychosocial interventions 
(also known as ‘talking therapies’) use psychological, psychotherapeutic and 
counselling skills to encourage change. Structured harm reduction interventions, on the 
other hand, include support to manage risky behaviour associated with substance 
misuse, such as overdose and accidental injury through substance misuse. In 2017-18, 
there were 9,612 (63%) young people receiving these interventions and 8,548 (55%) 
young people received both psychosocial and harm reduction interventions only. Only 
71 (less than 1%) young people received a pharmacological intervention in 2017-18. 
These interventions cover a wide range of medication prescribed by a clinician, and 
may involve detoxification, stabilisation, symptomatic relief from substance misuse and 
relapse prevention, as well as substitute prescribing for opiates. 
 
Table 4.2.1 Interventions received by young people in treatment in 2017-18  
(pre-November 2013 dataset change interventions) 
 
Intervention n 
Inpatient detoxification 0 
Other YP intervention 14 
 
Table 4.2.2 Interventions received by young people in treatment 2017-18 (post 
November 2013 dataset change interventions) 
 
Setting 
Intervention type 
Total 
individuals 
with this 
setting1 
Percentage 
of total 
individuals 
with this 
setting 
Psychosocial 
(n) 
Harm 
reduction 
(n) 
Pharmacological 
(n) 
Community 13,906 9,254 62 14,904 97% 
Home 423 358 6 488 3% 
YP Residential unit 29 17 * 36 <1% 
Adult setting 5 0 5 5 <1% 
YP Inpatient unit 8 * 0 8 <1% 
No setting recorded 0 0 0 0 - 
Total individuals2 14,308 9,612 71 15,340 100% 
% of total 
individuals with 
this intervention 
93% 63% <1% 
    
 
1 This is the total number of individuals receiving at least 1 intervention type in each setting and not a summation of the rows.  
2 This is the total number of individuals receiving each type of intervention and not a summation of the columns. 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest 5 and 
marked with an asterisk.  
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4.3 Length of latest treatment episode 
In 2017-18, there were 11,543 (75%) young people whose most recent episodes lasted 
for 26 weeks or less. Only 7% (1,053) of individuals were in treatment for longer than a 
year, which is the same proportion as in 2016-17. The average (mean) time was at 
least 5 (4.9) months. The results are shown in Table 4.3.1 below. 
 
Table 4.3.1 Length of latest episode 2017-18 
 
Episode length n % 
0 (zero) to 12 weeks 6,658 43% 
13 to 26 weeks 4,885 32% 
27 to 52 weeks 2,745 18% 
Longer than 52 weeks 1,053 7% 
Total 15,341 100% 
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5. Treatment exits 
5.1 Treatment exits 
The exit reasons for young people no longer in treatment at 31 March 2018 are 
reported in Table 5.1.1 and Figure 5.1.1. In 2017-18, 10,537 young people exited 
treatment, 68% of the total number of young people in treatment for the year (15,583). 
There were 8,511 (81%) young people exiting treatment in a planned way after 
completing specialist treatment and 1,206 (11%) leaving treatment in an unplanned 
way. This profile is roughly similar to 2016-17. 
 
Table 5.1.1 Treatment exit reasons of all young people exiting treatment 2017-18 
 
Treatment exit reason n % 
Completed  8,511  81% 
Dropped out / left  1,206  11% 
Referred on  559  5% 
Treatment declined by client  196  2% 
Other  41  <1% 
Prison  24  <1% 
Total 10,537 
 
 
Figure 5.1.1 Treatment exit reasons of all young people exiting treatment 2017-18 
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6. Trends over time 
6.1 Trends in age and numbers in treatment 
The number of young people attending specialist substance misuse services has fallen 
year-on-year, and has reduced by 35% when compared to 2008/09 (15,583 in 2017-18 
and 24,053 in 2008/09). This year, the number of young people attending services 
decreased by 5% from the previous year (16,436 in 2016-17 compared to 15,583 in 
2017-18). The numbers of young people in treatment from 2005-06 for each age group 
is shown in Figure 6.1.1 and Table 6.1.1. 
 
Despite an overall decrease in the number of young people in treatment since 2008-09, 
there was an increase in the younger age groups. There were 3,952 clients under the 
age of 15 in treatment in 2016-17 and this increased in 2017-18 to 4,037. The 
proportion of clients in the 14-15 age group increased from 14% in 2014-15 to 17% in 
2017-18. 
 
Figure 6.1.1 Number of young people in treatment by age group (2005-06 to 2017-18) 
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Table 6.1.1 Number of young people in treatment by age group (2005-06 to 2017-18) 
 
Age 
2005-06 2006-07 2007-08 2008-09 2009-10 2010-11 2011-12 
n % n % n % n % n % n % n % 
Under 12 212 1% 233 1% 227 1% 193 1% 155* 1% 128 1% 110 1% 
12-13 358 2% 457 2% 467 2% 442 2% 380* 2% 315 1% 323 2% 
13-14 1,040 6% 1,253 6% 1,476 6% 1500* 6% 1,396 6% 1,234 6% 1,129 5% 
14-15 2,380 14% 2,961 14% 3,466 14% 3550* 15% 3,300* 14% 3,092 14% 3,009 15% 
15-16 3,884 23% 4,953 23% 5,658 24% 5,574 23% 5,770 25% 5,445 25% 5,097 25% 
16-17 4,347 26% 5,315 25% 5,987 25% 6,133 25% 5,823 25% 5,657 26% 5,297 26% 
17-18 4,780 28% 6,019 28% 6,624 28% 6,663 28% 6,701 28% 6,084 28% 5,723 28% 
Total 17,001 100% 21,191 100% 23,905 100% 24,053 100% 23,528 100% 21,955 100% 20,688 100% 
 
Age 
2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 
n % n % n % n % n % n % 
Under 12 56 <1% 46 <1% 43 <1% 48 <1% 68 <1% 58 <1% 
12-13 310 2% 227 1% 225 1% 211 1% 284 2% 301 2% 
13-14 1,130 6% 1,008 5% 951 5% 909 5% 990 6% 1,063 7% 
14-15 2,936 15% 2,785 15% 2,643 14% 2,624 15% 2,610 16% 2,615 17% 
15-16 5,097 25% 4,922 26% 4,862 26% 4,476 26% 4,346 26% 4,202 27% 
16-17 5,040 25% 5,092 27% 4,866 27% 4,472 26% 4,109 25% 3,675 24% 
17-18 5,463 27% 5,046 26% 4,759 26% 4,337 25% 4,029 25% 3,669 24% 
Total 20,032 100% 19,126 100% 18,349 100% 17,077 100% 16,436 100% 15,583 100% 
 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest 5 and marked with an asterisk. 
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6.2 Trends in primary substance misuse 
The primary substance reported by young people for each year from 2005-06 to 2017-
18 is shown in Figure 6.2.1 and Table 6.2.1. Cannabis remained the most common 
drug by far that young people came to treatment for. The majority (88%) of young 
people in specialist services said they had a problem with this drug. The proportion of 
young people in treatment saying that cannabis is their main problem substance has 
been on an upward trend since 2007-08. Although total numbers have decreased 
slightly in recent years, the proportion of young people in treatment who have cannabis 
problems has remained stable in the last 2 years at 77%. Findings from the 2017-18 
Crime Survey for England and Wales show that cannabis use and prevalence is more 
likely to be common in the late teens/early 20s among young peoples.19 
 
The number of young people receiving help for alcohol problems continues to steadily 
decline from the peak in 2008-09 when 16,047 were treated for alcohol. The number of 
young people reporting a primary substance misuse of opiates has also fallen each 
year since 2005-06 to 76 young people in 2017-18. 
 
Benzodiazepine treatment is reported for the first time in this report. Young people who 
had problems with benzodiazepines at the start of treatment almost doubled from the 
previous year (161 in 2016-17 and 315 in 2017-18). Alprazolam (most commonly called 
Xanax) was the benzodiazepine which saw the biggest increase, (8 in 2016-17 to 53 in 
2017-18). 
 
Figure 6.2.1 shows the trend in cannabis and alcohol misuse among young people over 
the years since 2005-06. Section 6.3 explores trends in drug use other than cannabis 
and alcohol in more detail, including adjunctive use.  
 
 
 
 
 
 
 
 
 
 
 
 
                                            
 
 
19 Drug misuse: findings from the 2017/18 Crime Survey for England and Wales. Home Office 2018: 
www.gov.uk/government/statistics/drug-misuse-findings-from-the-2017-to-2018-csew 
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Figure 6.2.1 Number of young people in treatment by primary substance (2005-06 to 
2017-18) 
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Table 6.2.1 Number of young people in treatment by primary substance (2005-06 to 2017-18) 
 
Substance1 
2005-06 2006-07 2007-08 2008-09 2009-10 2010-11 2011-12 
n % n % n % n % n % n % n % 
Opiates 881 5% 755 4% 651 3% 547 2% 480* 2% 320* 1% 211 1% 
Amphetamines 332 2% 323 2% 346 1% 230* 1% 256 1% 639 3% 493 2% 
Cocaine 453 3% 655 3% 806 3% 745* 3% 457 2% 350* 2% 301 1% 
Crack 200 1% 137 1% 155 1% 110 <1% 50* <1% 35* <1% 40 <1% 
Ecstasy 325 2% 432 2% 438 2% 210* 1% 90* <1% 65* <1% 79 <1% 
Cannabis 9,043 55% 10,824 52% 12,021 51% 12,642 53% 13,123 56% 12,784 58% 13,200 64% 
Solvents 210 1% 301 1% 305 1% 284 1% 274 1% 263 1% 236 1% 
Alcohol 4,886 30% 7,039 34% 8,589 36% 8,799 37% 8,227 35% 7,054 32% 5,884 29% 
NPS  -   -   -   -   -   -   -   -   -   -   -   -   -   -  
Benzodiazepines1 -  -  -  -  -  -  -  - -  -  -  -  -  - 
Other2 174 1% 183 1% 241 1% 270* 1% 399 2% 349 2% 189 1% 
 
Substance1 
2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 
n % n % n % n % n % n % 
Opiates 175* 1% 160* 1% 134 1% 112 1% 94 1% 76 <1% 
Amphetamines 755* 4% 591 3% 540* 3% 317 2% 71 <1% 39 <1% 
Cocaine 245* 1% 254 1% 250* 1% 251 1% 254 2% 287 2% 
Crack 27 <1% 14 <1% 24 <1% 21 <1% 16 <1% 31 <1% 
Ecstasy 130* 1% 124 1% 165* 1% 261 2% 340 2% 454 3% 
Cannabis 13,581 68% 13,659 71% 13,454 73% 12,863 75% 12,712 77% 12,066 77% 
Solvents 163 1% 134 1% 135 1% 121 1% 128 1% 102 1% 
Alcohol 4,704 24% 3,776 20% 3,133 17% 2,556 15% 2,465 15% 2,265 15% 
NPS  -   -  120* 1% 334 2% 420 2% 213 1% 73 <1% 
Benzodiazepines2 -  - - -  -  -  -  -  -   - 75 <1% 
Other3 210* 1% 271 1% 165* 1% 148 1% 133 1% 105 1% 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest 5 and marked with an asterisk. 
1 Clients with missing primary substance or misuse free are not included in the breakdown and percentage calculations 
2 Benzodiazepines have been reported separately from the 'Other' category for the first time in 2017-18. 
3 From 2014-15, codes relating to prescribed opiates have been moved from the ‘Other’ category to ‘Opiates’. This affects a very small number of young people and the change has not 
been backdated.  
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6.3 Trends in other drug use (not cannabis or alcohol) 
Figure 6.3.1 and Table 6.3.1 report the total number of young people reporting 
substances other than cannabis and alcohol, and include both primary and adjunctive 
substance use. Figures were not recorded for adjunctive drug use prior to 2007-08. A 
breakdown of new psychoactive substances (NPS) based on their predominant effect is 
shown in Table 6.3.1 but is excluded from Figure 6.3.1 due to low numbers. 
 
Excluding cannabis and alcohol, ecstasy was the most cited substance in 2017-18. The 
number of young people entering treatment for problems with ecstasy in 2017-18 
increased by 16% from the previous year (1,815 to 2,112) and has almost doubled 
since 2013-14. The increase in ecstasy treatment numbers was seen across all age 
groups. 
 
Young people entering treatment for problems with new psychoactive substances 
(NPS) more than halved since the previous year (585 in 2016-17 and 270 in 2017-18) 
and is 74% lower than 2015-16 when 1,056 reported problematic use. Similar falls were 
seen in adults starting treatment over the same period, particularly in those under 25. 20 
NPS are chemical substances that produce similar effects to ‘established’ drugs (like 
cocaine, cannabis and ecstasy). Originally created to side-step legislation, an 
increasing number are controlled under the Misuse of Drugs Act 1971, but all remaining 
are now covered by the Psychoactive Substances Act 2016. Data on NPS use is 
reported here for the fifth year using a series of new drug codes describing NPS 
according to their predominant effect. The full breakdown of young people in treatment 
citing other drug use, including NPS use is shown in Table 6.3.1. 
 
The number of young people citing amphetamine use decreased by 45% between 
2016-17 and 2017-18 to 271 individuals. Solvent use also continued to decrease 
slightly, from 430 clients in 2016-17 to 387 in 2016-17 with the proportion of clients 
being roughly similar in both years (3% in 2016-17 and 2.5% in 2017-18). 
 
  
                                            
 
 
20 Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS) 2017-18: 
www.gov.uk/government/statistics/substance-misuse-treatment-for-adults-statistics-2017-to-2018 
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Figure 6.3.1 Trends in numbers in treatment for other drug use, excluding cannabis and 
alcohol (2007-08 to 2017-18) 
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Table 6.3.1 Trends in numbers in treatment for other drug use, excluding cannabis and alcohol (2007-08 to 2017-18)1 
 
Substance 
2007-
08 
2008-
09 
2009-
10 
2010-
11 
2011-
12 
2012-
13 
2013-
14 
2014-
15 
2015-
16 
2016-
17 
2017-
18 
Ecstasy 2,281 1,644 1,183 746 732 997 1,084 1,338 1,605 1,815 2,112 
Cocaine 2,852 3,050 2,386 1,890* 1,630* 1,435* 1,499* 1,432 1,477 1,473 1,495 
NPS (any) 2  - -   -  -  -  - 324 887 1,056 585 270 
NPS - Predominantly stimulant 2  -  -  -  -  -  - 60 154 121 50 33 
NPS - Predominantly hallucinogenic 2  -  -  -  -  -  - 29 46 37 18 14 
NPS - Predominantly dissociative 2  -  -  -  -  -  - * 5 32 20 13 
NPS - Predominantly sedative/opioid 2  -  -  -  -  -  - * 9 13 * * 
NPS - Predominantly cannabinoid 2  -  -  -  -  -  - 203 557 695 407 168 
NPS – other 2  -  -  -  -  -  - 39 139 175 91 43 
Amphetamines 1,259 1,116 1,063 1,977 1,836 2,280* 1,961* 1,740* 1,152 491 271 
Solvents  310* 562 559* 503 451 338* 294* 357 441 430 387 
Opiates 889 751 670 479 326 285 265 220 206 181 187 
 
1 Primary and adjunctive use are combined in this table, therefore a young person may be counted more than once in this table. 
2 Codes for NPS were added to the NDTMS core data set in 2013-14. Any individuals reporting NPS prior to this are counted in the ‘Any club drug cited’ total but no separate totals are 
given for NPS. An individual may report more than 1 NPS drug and therefore the sum of individual NPS drugs may exceed the total number of clients reported for NPS (any). 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest 5 and marked with an asterisk. 
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6.4 Trends in treatment exit reasons 
Table 6.4.1 shows treatment exit reasons for young people leaving treatment between 
2005-06 and 2017-18. In 2009, a new discharge coding system was introduced that 
tightened the way ‘treatment completed’ was recorded. These changes mean it is not 
possible to directly compare treatment exit data from 2009-10 onwards with previous 
years. For further details, see: www.ndtms.net/resources/public/Quality-and-
Methodology-NDTMS-2017-18.pdf  
 
Almost 4 in 5 (81%) young people discharged from treatment had completed their 
treatment. This is similar to the previous year (82%). A further 11% dropped out of 
treatment. This proportion has remained unchanged since 2014-15. Those being 
transferred for further structured drug and/or alcohol treatment increased slightly from 
4% in 2016-17 to 5% in 2017-18.  
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Table 6.4.1 Trends in treatment exit reasons (2005-06 to 2017-18) 
 
Treatment exit reason 
2005-06 2006-07 2007-08 2008-09 2009-10 2010-11 2011-12 
n % n % n % n % n % n % n % 
Completed 4,105 48% 5,726 50% 8,073 57% 9,546 65% 10,160 69% 10,507 75% 10,118 77% 
Referred on 572 7% 701 6% 938 7% 510 3% 856 6% 793 6% 841 6% 
Dropped out / left 2,525 29% 2,902 25% 2,529 18% 2,253 15% 2,408 16% 1,851 13% 1,630 12% 
Prison 200 2% 285 2% 339 2% 371 3% 183 1% 139 1% 97 1% 
Treatment declined by client * 0% 246 2% 703 5% 620* 4% 529 4% 440 3% 326 2% 
Not known 102 1% 202 2% 98 1% 71 <1% 51 <1% 16 <1% 0 0% 
Other 1,108 13% 1,448 13% 1,401 10% 1,250 9% 478 3% 260 2% 175 1% 
Total 8,615* 100% 11510 100% 14081 100% 14,620* 100% 14,665 100% 14,006 100% 13,187 100% 
 
Treatment exit reason 
2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 
n % n % n % n % n % n % 
Completed 10,208 79% 9,852 79% 9,613 80% 8,929 80% 8,842 82% 8,511 81% 
Referred on 760 6% 852 7% 773 6% 722 6% 469 4% 559 5% 
Dropped out / left 1,530 12% 1,440 12% 1,345 11% 1,237 11% 1,178 11% 1,206 11% 
Prison 66 1% 62 <1% 52 <1% 31 <1% 43 <1% 24 <1% 
Treatment declined by client 278 2% 244 2% 236 2% 245 2% 197 2% 196 2% 
Not known 0 0% 0 0% 0 0% 0 0% 0 0% ** - 
Other 105 1% 60 <1% 55 <1% 60 1% 105 1% 41 <1% 
Total 12,947 100% 12,510 100% 12,074 100% 11,224 100% 10,834 100% 10,537 100% 
 
 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest 5 and marked with an asterisk. 
** Due to low numbers, the number of ‘Not known’ cases have been grouped under the ‘Other’ category in 2017-18. 
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7. History 
This report presents information relating to drug and alcohol treatment in England. The 
statistics are derived from data that has been collected through NDTMS. NDTMS 
collects activity data from substance misuse treatment services so that: 
 
 the progress of individuals entering treatment may be monitored and their outcomes 
assessed  
 trends and shifts in patterns of drug and alcohol use can be monitored, to inform 
future planning locally and nationally  
 the impact of substance misuse treatment as a component of the wider public health 
service may be measured 
 treatment services can demonstrate their accountability to young people, parents 
and carers, local commissioners and communities  
 costs can be benchmarked against data from comparable areas to show how 
efficiently they use resources and how they are delivering value for money 
 
Drug treatment activity has been collected nationally for nearly 25 years and has been 
routinely collected through NDTMS since April 2004. NDTMS is currently managed by 
PHE. 
 
NDTMS has been reorganised over the years, bringing the definition of alcohol and 
drug treatment recorded by the system further into line with ‘Drug misuse and 
dependence: UK guidelines on clinical management’: 
www.gov.uk/government/publications/drug-misuse-and-dependence-ukguidelines- 
on-clinical-management and ‘Models of care for alcohol 
misusers’: webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.go 
v.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4
136809.pdf 
 
Since 2003-04 data has been consistently collected by treatment services, submitting a 
core data set of their clients’ information as a database extract. The most recent 
revision affecting the statistics in this document is the introduction of core dataset N for 
the April 2017 data submission. The core data set can be found in NDTMS reference 
data document: www.gov.uk/government/collections/alcohol-and-drug-
misusetreatment-core-dataset-collection-guidance 
 
Periodic consultations are undertaken to revise the NDTMS dataset. Information 
regarding future core dataset consultations will be made available here: 
www.gov.uk/government/collections/alcohol-and-drug-misusetreatment-core-dataset-
collection-guidance 
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NDTMS figures for England are collated by The National Drug Evidence Centre 
(NDEC), along with those for Scotland, Wales and Northern Ireland, and combined into 
a UK return for use by the European Monitoring Centre for Drugs and Drug Addiction 
www.emcdda.europa.eu/html.cfm/index190EN.html (and for the United Nations). 
 
This statistical release covers England only. Information on drug and alcohol treatment 
in Wales, Scotland and Northern Ireland is also available: 
www.wales.gov.uk/keypubstatisticsforwales/topicindex/topics.htm#public (Wales) 
www.scotpho.org.uk/comparative-health/profiles/online-profiles-tool (Scotland) 
www.dhsspsni.gov.uk/articles/drugs-statistics (Northern Ireland) 
 
While comparisons to substance misuse statistics concerning young people from other 
countries can be made, care needs to be taken when doing so, as the data is unlikely 
to be directly comparable due to differences in the definitions and methodologies that 
are used in collecting the data and in subsequently reporting it. 
 
7.1 Relevant web links and contact details 
Monthly web-based NDTMS analyses: 
www.ndtms.net/ 
 
Public Health Outcomes Framework indicators 2.15i, 2.15ii, 2.15iii and 2.15iv:  
fingertips.phe.org.uk/profile/public-health-outcomes-
framework/data#page/0/gid/1000042/pat/6/par/E12000002/ati/101/are/E07000029 
 
National Drug Evidence Centre (NDEC): 
research.bmh.manchester.ac.uk/epidemiology/NDEC/ 
 
Public Health England: 
www.gov.uk/government/organisations/public-health-england 
 
General enquiries 
For media enquiries, call 020 3682 0574 or email phe-pressoffice@phe.gov.uk 
For technical enquiries, email EvidenceApplicationteam@phe.gov.uk 
 
Policy 
Evidence application team, PHE 
EvidenceApplicationteam@phe.gov.uk 
 
Data and statistics 
Jonathan Knight, Head of Evidence Application, PHE 
Jonathan.Knight@phe.gov.uk  
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Kevin Shelton, senior programme manager, PHE 
Kevin.Shelton@phe.gov.uk 
 
Brian Eastwood, programme manager, PHE 
Brian.Eastwood@phe.gov.uk 
 
Solina Li, senior information analyst, PHE 
Solina.Li@phe.gov.uk 
 
Arshad Emmambux, information analyst, PHE 
Arshad.Emmambux@phe.gov.uk 
 
Stefan Jahr, senior information analyst, NDEC 
Stefan.Jahr@manchester.ac.uk 
 
7.2 Comparability of data to previous reports 
Since 1 November 2013, PHE made substantial changes to the core dataset with 
regards to young people and the coding of intervention type. Prior to this, intervention 
codes were restricted to 8 categories:  
 
 harm reduction 
 pharmacological 
 psychosocial (counselling) 
 psychosocial (cognitive behaviour therapy) 
 psychosocial (motivational interviewing 
 psychosocial (relapse prevention) 
 psychosocial (family work) 
 the setting where the interventions were being delivered was not recorded 
 
Following consultations with clinicians, treatment providers and other key stakeholders, 
a new method of recording interventions types and setting was introduced alongside 
the ability for providers to record the non-structured multi-agency working interventions 
that they were delivering. These changes enable a better understanding of the different 
interventions being provided nationally and in local areas, which will in turn benefit 
commissioning and service planning as well as influencing national policy setting.  
From 1 November 2013, all registered young people’s treatment providers are 
registered with 1 of 7 setting types:  
 
 community 
 home 
 secure estate 
 in-patient (substance misuse specific) 
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 in-patient (not substance misuse specific) 
 residential (substance misuse specific) 
 residential (not substance misuse specific), which have now been incorporated to 
PHE’s regular reporting  
 
Clients in secure estate settings are not reported on in this document. Definitions of 
these settings can be found in the business definitions guide at: 
assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data
/file/689473/Young_peoples_treatment_business_definitions_core_dataset_N.pdf 
 
Intervention types have been split in to 4 high-level categories:  
 
 pharmacological interventions 
 psychosocial interventions 
 harm reduction interventions 
 multi-agency working interventions 
 
Multi agency working interventions are not reported on in the present report. Other 
changes to the core dataset with regards to young people also occurred in the dataset 
change on 1 November 2013. Valid responses to accommodation status and education 
and employment status were changed at this time. For more details please see the 
latest business definitions at: www.gov.uk/government/publications/business-
definitions-for-young-people-drug-and-alcohol-treatment-providers 
 
The final change following the consultations with clinicians, treatment providers and 
other key stakeholders was to introduce a new set of questions to capture 
vulnerabilities, risk and resilience factors at the start of treatment. 
 
The 2 main changes in this year’s report are that a new section on mental health 
treatment need (section 2.9) has been introduced and benzodiazepines has been 
separated from the other substance group.  
 
7.3 Drug treatment collection and reporting timeline 
1989 to March 2001 Regional Drug Misuse Database (RDMD) – statistics reported in 6 
monthly bulletins by DH from 1993 to 2001: 
webarchive.nationalarchives.gov.uk/20120907233254/http://www.dh.gov.uk/en/Publicat
ionsandstatistics/Statistics/StatisticalWorkAreas/Statisticalpublichealth/DH_4015620 
 
April 2001 to March 2004 NDTMS - statistics reported annually by the Department of 
Health (DH). 
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April 2004 to March 2013 NDTMS - managed by the National Treatment Agency (NTA) 
reporting statistics annually up to March 2012. 
 
April 2013 to date NDTMS - managed by Public Health England (PHE) reporting 
statistics annually from April 2012. 
 
7.4 Other sources of statistics about drugs and alcohol 
7.4.1 Prevalence of substance use 
Information is available relating to the prevalence of drug use among secondary school 
pupils aged 11 to 15 from the Smoking, Drinking and Drug Use Survey among young 
people in England. This is a survey carried out for the NHS Information Centre by the 
National Centre for Social Research and the National Foundation for Educational 
Research. The survey interviews school pupils, and has been in place since 2001. It 
reported annually up to 2014-15 and the latest report for 2016-17 was published on 2 
November 2017. The data and further information are available at: digital.nhs.uk/data-
and-information/publications/statistical/smoking-drinking-and-drug-use-among-young-
people-in-england/2016 
 
Findings from a survey called ‘What About YOUth’ were published in December 2015. 
It asked 15-year olds about a range of subjects including what they eat, what they do in 
their free time, bullying and whether they smoke, drink alcohol or have taken drugs. 
Local level data on drug and alcohol use is available at: www.whataboutyouth.com 
An annual estimate of the prevalence of drug use is undertaken through the Crime 
Survey for England and Wales (CSEW; formerly the British Crime Survey). This section 
of the survey has been in place since 1996, annually since 2001, and has tracked the 
prevalence of the use of different drugs over this time. This does not include 
information on all young people but does show the data for the age group 16 to 24: 
www.gov.uk/government/statistics/drug-misuse-findings-from-the-2017-to-2018-csew 
 
A second method is used to produce estimates for the prevalence of opiate and/or 
crack cocaine use for people aged 15-64 (with estimates broken down by age group, 
the youngest being 15 to 24) each local authority area in England. Estimates are 
available for 2004-05, 2005-06, 2006-07, 2008-09, 2009-10, 2010-11, 2011-12 and 
2014-15. 
 
The estimates are produced through a mixture of capture-recapture and Multiple 
Indicator Methodology (MIM), and rely on NDTMS (community and prison) data being 
matched against and/or analysed alongside Probation and Home Office data sets. The 
data and further information are available at: 
www.gov.uk/government/collections/alcohol-and-drug-misuse-and-treatment-
statistics#prevalence-data-and-analysis 
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7.4.2 Youth justice statistics 
The Ministry of Justice and the Youth Justice Board for England and Wales publish 
annual statistics that detail the number of young people (aged 10 to 17) arrested, along 
with proven offences, criminal history, characteristics of young people, the number 
sentenced, those on remand, those in custody, re-offending and behaviour 
management: www.gov.uk/government/collections/youth-justice-annual-statistics 
 
In addition, NDTMS collects data on drug and alcohol treatment in secure settings and 
will produce the next set of official statistics for 2017-18 on 17 January 2019. This will 
include information on young people accessing treatment in secure settings. The report 
will be available at: www.gov.uk/government/collections/alcohol-and-drug-misuse-and-
treatment-statistics#alcohol-and-drug-treatment-statistics:-prisons-and-secure-settings 
 
7.4.3 International comparisons 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) publishes 
an annual report that describes and compares aspects of drug use and drug policy 
within European states, as well as providing detailed comparative statistics. This can 
be found at: www.emcdda.europa.eu/data/stats2018_en 
 
The centre also produces a treatment demand indicator (TDI), which is a collection of 
comparative statistics relating to individuals seeking treatment. This can be found at: 
www.emcdda.europa.eu/data/stats2018/tdi 
 
While comparisons to alcohol treatment statistics from other countries can be made, 
care needs to be taken as the data is unlikely to be directly comparable due to 
differences in the definitions and methodologies that are used in collecting the data and 
subsequently in reporting it. 
 
7.4.4 Adult drug and alcohol treatment 
PHE also publishes annual reports regarding adults accessing drug and alcohol 
treatment. These can be found at: www.gov.uk/government/collections/alcohol-and-
drug-misuse-and-treatment-statistics#alcohol-and-drug-treatment-statistics:-adults 
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Note that young people’s figures are not comparable with statistics relating to adult 
drug or alcohol treatment. This is because access to specialist services for young 
people requires a ‘lower severity of drug use and associated problems’21. 
 
7.4.5 Drug related deaths 
The Office for National Statistics publishes an annual summary of all deaths related to 
drug poisoning (involving both legal and illegal drugs) and drug misuse (involving illegal 
drugs) in England and Wales. This covers all ages with young people forming part of 
the ‘under 20’ age group and can be found at: 
www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bull
etins/deathsrelatedtodrugpoisoninginenglandandwales/2017registrations 
 
 
  
                                            
 
 
21 Drug Misuse and Dependence – UK Guidelines on Clinical Management, p.85, London: Department of Health (England), the 
Scottish Government, Welsh Assembly Government and Northern Ireland Executive. 
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8. Abbreviations and definitions 
8.1 Abbreviations 
A&E Accident and emergency department 
CAMHS Child and adolescent mental health services  
CSE Child sexual exploitation 
CSEW Crime Survey for England and Wales 
DfE Department for Education 
DHSC Department of Health and Social Care 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
GP General practitioners 
HBSC Health Behaviour in School-aged Children 
MIM Multiple Indicator Methodology 
NDEC National Drug Evidence Centre  
NDTMS National Drug Treatment Monitoring System 
NEET Not in education, employment or training 
NO Nitrous oxide 
NPS New psychoactive substances 
ONS Office for National Statistics 
PHE Public Health England 
TDI Treatment Demand Indicator 
YOT Youth offending team 
YP Young people 
 
8.2  Definitions 
Adjunctive drug 
use 
Substances additional to the primary substance used by the 
individual, NDTMS collects secondary and tertiary 
substances. 
Agency /provider A provider of services for the treatment of substance 
misuse. They may be statutory (i.e. the NHS) or non-
statutory (i.e. third sector, charitable). 
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Attributor A concatenation of a client’s initials, date of birth and 
gender. This is used to isolate records that relate to 
individual clients. 
Client A drug or alcohol user presenting for treatment at a 
structured treatment service. Records relating to individual 
clients are isolated and linked based on the attributor. 
Community setting A young person’s drug and alcohol service where residence 
is not a condition of engagement with that service. This will 
include all providers delivering interventions in a non-
residential setting.  
Discharge date This is usually the planned discharge date in a client’s 
treatment plan, where one has been agreed. However, if a 
client's discharge was unplanned, then the date of last face-
to-face contact with the provider (agency) is used. 
 
Drug-related death 
/ drug misuse 
death 
Annual figures published by the Office for National Statistics 
(ONS) since 1993 cover deaths in England and Wales 
related to “drug poisoning (involving both legal and illegal 
drugs)” and to “drug misuse (involving illegal drugs)”. 
 
The ONS's definition of a drug misuse death is “(a) deaths 
where the underlying cause is drug abuse or drug 
dependence and (b) deaths where the underlying cause is 
drug poisoning and where any of the substances controlled 
under the Misuse of Drugs Act 1971 are involved". 
 
Where people do suffer drug poisonings while in treatment, 
these are overwhelmingly classed as drug misuse, so this 
definition may be seen as more relevant to this population. 
However, many of those who die in treatment are not 
included under either definition as they die from causes 
other than poisoning. 
Episode A period of contact with a treatment provider (agency): from 
referral to discharge. 
Episode of 
treatment 
A set of interventions with a specific care plan. A client may 
attend 1 or more interventions (or types) of treatment during 
the same episode of treatment. A client may also have more 
than 1 episode in a year. A client is considered to have been 
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in contact during the year, and hence included in these 
results, if any part of an episode occurs within the year. 
Where several episodes were collected for an individual, 
attributes such as ethnicity, primary substance, etc. are 
based on the first valid data available for that individual. 
 
Family work 
intervention 
Interventions using psychosocial methods to support 
parents, carers and other family members to manage the 
impact of a young person’s substance misuse and enable 
them to better support the young person in their family. 
First/subsequent 
intervention 
First intervention' refers to the first intervention that occurs in 
a treatment journey. 'Subsequent intervention' refers to 
interventions, within a treatment journey, that occur after the 
first intervention. 
Home setting The young person is being supported with specialist 
substance misuse interventions in his/her home by the 
treatment provider. 
In contact Clients are counted as being in contact with treatment 
services if their date of presentation (as indicated by 
triage/initial assessment), intervention start, intervention end 
or discharge indicates that they have been in contact with a 
provider during the year. 
Inpatient unit (not 
substance misuse 
specific) setting 
An inpatient unit provides assessment, stabilisation and/or 
assisted withdrawal with 24-hour cover. Such as a hospital 
unit.  
Inpatient unit 
(substance misuse 
specific) setting 
An inpatient unit provides assessment, stabilisation and/or 
assisted withdrawal with 24-hour cover from a multi-
disciplinary team who have had specialist training in 
managing addictive behaviours. Such as paediatric ward, 
adult ward, child and adolescent mental health ward, etc.  
Intervention A type of treatment, e.g. structured counselling, community 
prescribing, etc. 
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Looked after child The definition of a looked after child (from the Children Act 
198922) is “Children looked after includes all children being 
looked after by a local authority including those subject to 
care orders under section 31 of the Children Act 1989 and 
those looked after on a voluntary basis through an 
agreement with their parents under section 20 of the 
Children Act 1989”. 
New psychoactive 
substance (NPS) 
Chemical substances that produce similar effects to 
‘established’ drugs (like cocaine, cannabis and ecstasy). 
Originally created to side-step legislation, an increasing 
number are controlled under the Misuse of Drugs Act 1971 
but all remaining are now covered by the Psychoactive 
Substances Act 2016.  
Opiate A group of drugs including heroin, methadone and 
buprenorphine that act on opioid receptors. 
Pharmacological 
intervention 
Interventions that include prescribing for detoxification, 
stabilisation and symptomatic relief of substance misuse as 
well as prescribing to prevent relapse. For young people this 
intervention includes a wide range of medication prescribed 
by a clinician, not solely substitute prescribing for opiate 
addiction. 
Planned discharge A treatment exit where the discharge reason is 'treatment 
completed'. This includes ‘Treatment 
completed – Drug free’ and ‘Treatment Completed - 
Occasional user’ from the current core data set. It also 
includes any codes from previous datasets that begin with 
‘Treatment completed’ or ‘completed’. 
Poly drug use The reporting of using 2 or more drugs in combination. 
Presenting for 
treatment 
The first face-to-face contact between a client and a 
treatment provider.  
Primary 
drug/substance 
The substance that brought the client into treatment at the 
point of triage/initial assessment. 
                                            
 
 
22 The Children’s Act 1989 can be found here: www.legislation.gov.uk/ukpga/1989/41/contents 
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Psychosocial 
Intervention 
These interventions use psychological, psychotherapeutic, 
counselling and counselling based techniques to encourage 
behavioural and emotional change; the support of lifestyle 
adjustments and the enhancement of coping skills. They 
include motivational interviewing, relapse prevention and 
interventions designed to reduce or stop substance misuse, 
as well as interventions that address the negative impact of 
substance misuse on offending and attendance at 
education, employment or training. 
Referral date The date the client was referred to the provider for this 
episode of treatment. 
Residential unit 
(not substance 
misuse specific) 
setting 
Anywhere where a young person is receiving interventions 
in their residence but that residence has not been set up 
specifically to deal with substance misuse, such as 
children’s homes, supported housing etc.  
Residential unit 
(substance misuse 
specific) setting 
Anywhere where a young person is receiving interventions 
in their residence and that residence has been set up 
specifically to deal with substance misuse.  
Specialist harm 
reduction 
intervention 
Care planned substance misuse specific harm reduction is 
not brief advice and information; this intervention must be 
delivered as part of a structured care plan and after a full 
assessment of the young person’s substance misuse and 
risks. Specialist harm reduction interventions should include 
services to manage those at risk of, or currently involved in: 
 
Injecting: these services could include needle exchange, 
advice and information on injecting practice, access to 
appropriate testing and treatment for blood borne viruses 
 
Overdose: advice and information to prevent overdose, 
especially overdose associated with poly-substance use, 
which requires specialist knowledge about substances and 
their interactions 
 
Risky behaviour associated with substance use: advice and 
information to prevent and/or reduce substance misuse 
related injuries and substance misuse related risky 
behaviours 
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Structured 
treatment 
Structured treatment follows assessment and is delivered 
according to a care plan, with clear goals, which are 
regularly reviewed with the client. It may comprise a number 
of concurrent or sequential treatment interventions.  
Triage An initial clinical risk assessment performed by a treatment 
provider. A triage includes a brief assessment of the 
problem as well as an assessment of the client’s readiness 
to engage with treatment, in order to inform a care plan. 
Triage date The date that the client made a first face-to-face 
presentation to a treatment provider. This could be the date 
of triage/initial assessment though this may not always be 
the case. 
Waiting times The period from the date a person is referred for a specific 
treatment intervention and the date of the first appointment 
offered. Referral for a specific treatment intervention 
typically occurs within the treatment provider, at or following 
assessment. 
Young people Person under 18 years old. 
YP secure estate Establishments that house young offenders who have been 
remanded or sentenced, they include young offender 
institutes, secure training centres and secure children’s 
homes. 
 
 
Note: full operational definitions can be found in the NDTMS core data set documents 
on: www.gov.uk/government/publications/business-definitions-for-young-people-drug-
and-alcohol-treatment-providers 
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Appendix A 
Diagram to show an example young people’s pathway 
This diagram illustrates a typical journey through a young people’s specialist substance 
misuse service. It is provided to give an indication of a possible pathway and the 
interventions received. Pathways will vary depending on the substances used, the 
support requirements of the young people, their general health needs and any other 
relevant issues. Young people with substance misuse problems will usually have a 
number of other issues that they are receiving help with, but this pathway focuses on 
the substance misuse. 
 
 
 
Referral to young people’s 
specialist substance misuse 
interventions (e.g. from school and 
youth justice system) 
Young person no longer in need of 
substance misuse 
interventions/discharge successfully 
Specialist substance 
misuse assessment 
Care plan agreed between 
young person, keyworkers 
and parents/carers where 
appropriate 
Treatment intervention 
started, Young person 
outcome record at baseline 
carried out 
Care plan and 
interventions 
complete/YPOR exit review 
carried out 
Multi-agency working to 
support other health and 
social issues e.g. sexual 
health provision, resilience 
building, youth work 
